Search research articles
Contact Us
Filters
Showing results (31-40 of 44) with videos related to
Page
of 5
Sort By:
Frontiers in Oncology
|
April 5, 2021
TMPRSS4 Promotes Cell Proliferation and Inhibits Apoptosis in Pancreatic Ductal Adenocarcinoma by Activating ERK1/2 Signaling Pathway
Jianyou Gu, Wenjie Huang, Junfeng Zhang, et al.
Cancer Cell International
|
December 20, 2022
Increased expression of miR-194-5p through the circPVRL3/miR-194-5p/SOCS2 axis promotes proliferation and metastasis in pancreatic ductal adenocarcinoma by activating the PI3K/AKT signaling pathway
Bojing Chi, Yao Zheng, Fuming Xie, et al.
Bioactive Materials
|
January 15, 2026
A promising magnesium-related alloy with metabolic reprogramming and antitumor effects in hepatocellular and pancreatic cancer
Junfeng Zhang, Jianyou Gu, Renpei Xia, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
July 25, 2024
Identifying suitable candidates for pancreaticoduodenectomy with extended lymphadenectomy for pancreatic ductal adenocarcinoma
Jiali Yang, Junfeng Zhang, Mingda Tan, et al.
Aging
|
November 22, 2020
Alteration of tumor-associated macrophage subtypes mediated by KRT6A in pancreatic ductal adenocarcinoma
Junfeng Zhang, Hui Sun, Songsong Liu, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
January 30, 2024
The role of histone H1.2 in pancreatic cancer metastasis and chemoresistance
Jianyou Gu, Junfeng Zhang, Renpei Xia, et al.
Frontiers in Oncology
|
June 5, 2023
Corrigendum: The m6A methyltransferase METTL16 inhibits the proliferation of pancreatic adenocarcinoma cancer cells via the p21 signaling pathway
Fuming Xie, Yao Zheng, Wen Fu, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
April 21, 2026
Targeting keratin 6 A overcomes gemcitabine resistance by restoring equilibrative nucleoside transporter 1 and TAM-mediated metabolic compensation in pancreatic cancer
Junfeng Zhang, Xianxing Wang, Silue Zeng, et al.
Molecular Cancer
|
May 10, 2022
Hsa-miR-3178/RhoB/PI3K/Akt, a novel signaling pathway regulates ABC transporters to reverse gemcitabine resistance in pancreatic cancer
Jianyou Gu, Wenjie Huang, Xianxing Wang, et al.
Frontiers in Oncology
|
May 14, 2023
The m6A methyltransferase METTL16 inhibits the proliferation of pancreatic adenocarcinoma cancer cells <i>via</i> the p21 signaling pathway
Fuming Xie, Yao Zheng, Wen Fu, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 44) with videos related to
Sort By:
Page
of 5
Frontiers in Oncology
|
April 5, 2021
TMPRSS4 Promotes Cell Proliferation and Inhibits Apoptosis in Pancreatic Ductal Adenocarcinoma by Activating ERK1/2 Signaling Pathway
Jianyou Gu, Wenjie Huang, Junfeng Zhang, et al.
Cancer Cell International
|
December 20, 2022
Increased expression of miR-194-5p through the circPVRL3/miR-194-5p/SOCS2 axis promotes proliferation and metastasis in pancreatic ductal adenocarcinoma by activating the PI3K/AKT signaling pathway
Bojing Chi, Yao Zheng, Fuming Xie, et al.
Bioactive Materials
|
January 15, 2026
A promising magnesium-related alloy with metabolic reprogramming and antitumor effects in hepatocellular and pancreatic cancer
Junfeng Zhang, Jianyou Gu, Renpei Xia, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
July 25, 2024
Identifying suitable candidates for pancreaticoduodenectomy with extended lymphadenectomy for pancreatic ductal adenocarcinoma
Jiali Yang, Junfeng Zhang, Mingda Tan, et al.
Aging
|
November 22, 2020
Alteration of tumor-associated macrophage subtypes mediated by KRT6A in pancreatic ductal adenocarcinoma
Junfeng Zhang, Hui Sun, Songsong Liu, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
January 30, 2024
The role of histone H1.2 in pancreatic cancer metastasis and chemoresistance
Jianyou Gu, Junfeng Zhang, Renpei Xia, et al.
Frontiers in Oncology
|
June 5, 2023
Corrigendum: The m6A methyltransferase METTL16 inhibits the proliferation of pancreatic adenocarcinoma cancer cells via the p21 signaling pathway
Fuming Xie, Yao Zheng, Wen Fu, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
April 21, 2026
Targeting keratin 6 A overcomes gemcitabine resistance by restoring equilibrative nucleoside transporter 1 and TAM-mediated metabolic compensation in pancreatic cancer
Junfeng Zhang, Xianxing Wang, Silue Zeng, et al.
Molecular Cancer
|
May 10, 2022
Hsa-miR-3178/RhoB/PI3K/Akt, a novel signaling pathway regulates ABC transporters to reverse gemcitabine resistance in pancreatic cancer
Jianyou Gu, Wenjie Huang, Xianxing Wang, et al.
Frontiers in Oncology
|
May 14, 2023
The m6A methyltransferase METTL16 inhibits the proliferation of pancreatic adenocarcinoma cancer cells <i>via</i> the p21 signaling pathway
Fuming Xie, Yao Zheng, Wen Fu, et al.
Page
of 5